✦ LIBER ✦

Phase 2 Trial of Liposomal Doxorubicin (40 mg/m2) in Platinum/Paclitaxel-Refractory Ovarian and Fallopian Tube Cancers and Primary Carcinoma of the Peritoneum

✍ Scribed by Maurie Markman; Alexander Kennedy; Kenneth Webster; Gertrude Peterson; Barbara Kulp; Jerome Belinson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial of single agent docetaxel

✍ Maurie Markman; Kristine Zanotti; Kenneth Webster; Gertrude Peterson; Barbara Ku 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Phase 2 trial of carboplatin, paclitaxel

✍ Pedro F Escobar; Maurie Markman; Peter Rose; Kristine Zanotti; Kenneth Webster; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Phase 2 trial of prolonged administratio

✍ Maurie Markman; Kenneth Webster; Kristine Zanotti; Barbara Kulp; Gertrude Peters 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Phase 2 trial of carboplatin plus tamoxi

✍ Maurie Markman; Kenneth Webster; Kristine Zanotti; Gertrude Peterson; Barbara Ku 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Phase 2 study of canfosfamide in combina

✍ John J Kavanagh; Charles F Levenback; Pedro T Ramirez; Judith L Wolf; Carla L Mo 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 404 KB

Phase II trial of weekly paclitaxel (80

✍ Maurie Markman; John Blessing; Stephen C. Rubin; Joseph Connor; Parviz Hanjani; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 97 KB